Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

SAN CARLOS, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences:

Click to view original post